Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study
Journal of Korean Medical Science · 2025
DOI: 10.3346/jkms.2025.40.e82 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Seohyun Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Cat…. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Drug Treatment, Steroids, Adrenal Cortex Hormones. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: The impact of steroid treatment on mortality outcomes in patients with coronavirus disease 2019 (COVID-19) has been widely demonstrated, while its effect on secondary infections, such as bloodstream infections (BSIs), is controversial. Recent studies have reported the survival benefits of using steroids for a standard duration compared to extended use, though their impact on the risk of BSIs remains debated. This study investigated whether extended steroid use is associated with the risk of BSIs and mortality in critically ill patients with COVID-19. METHODS: This national multicenter retrospective study conducted at 22 university-affiliated hospitals evaluated the effect of steroid treatment duration in hospitalized patients with COVID-19 treated with more than high-flow nasal cannula therapy. Patients were divided into two groups according to the duration of corticosteroid treatment: extended (> 10 days) and standard (≤ 10 days). Propensity score matching was performed by adjusting for covariates. Baseline characteristics and clinical outcomes were compared between the two groups. RESULTS: Among 1,114 patients, 378 with a hospital length of stay (LOS) exceeding 10 days were included. Each group of the propensity score-matched cohort had 189 patients, with no significant differences in demographic characteristics between the two groups, except for the incidence of BSIs (extended group vs. standard group, 49.7% vs. 36.0%, P = 0.043). After adjusting for confounding factors, extended use of steroids remained significantly associated with BSIs (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.25-4.04; P = 0.007). The use of a mechanical ventilator, extracorporeal membrane oxygenation, continuous renal replacement therapy, and a longer hospital LOS were associated with BSIs. In-hospital mortality was associated with an older age, higher body mass index, higher sequential organ failure assessment score at admission, and the presence of a BSI (OR, 2.47; 95% CI, 1.50-4.05; P < 0.001). Kaplan-Meier survival analysis demonstrated no significant difference in in-hospital mortality between the extended and standard groups. CONCLUSION: Extended steroid therapy was significantly associated with a higher incidence of BSIs in critically ill patients with COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
- Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
- BioMedical Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.
ORCID-Profile: Seohyun Kim, Jiwon Ryoo, Hyeong Jun Cho, Seok Chan Kim, Sunghoon Park, Su Hwan Lee, Onyu Park, Taehwa Kim, Hye Ju Yeo, Jin Ho Jang, Woo Hyun Cho, Jongmin Lee
Zitieren
APA
Kim, S., Ryoo, J., Cho, H. J., Kim, S. C., Park, S., Lee, S. H., Park, O., Kim, T., Yeo, H. J., Jang, J. H., Cho, W. H., Lee, J., & Korean Intensive Care Study Group (2025). Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2025.40.e82
Vancouver
Kim S, Ryoo J, Cho HJ, Kim SC, Park S, Lee SH, et al. Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2025.40.e82
BibTeX
@article{Kim2025,
author = {Kim, Seohyun and Ryoo, Jiwon and Cho, Hyeong Jun and Kim, Seok Chan and Park, Sunghoon and Lee, Su Hwan and Park, Onyu and Kim, Taehwa and Yeo, Hye Ju and Jang, Jin Ho and Cho, Woo Hyun and Lee, Jongmin and Korean Intensive Care Study Group, Korean Intensive Care Study Group},
title = {Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study},
journal = {Journal of Korean Medical Science},
year = {2025},
doi = {10.3346/jkms.2025.40.e82}
}
EUVIMED